RBC Capital Maintains Outperform on Medpace Holdings, Raises Price Target to $692
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
RBC Capital analyst Ryan Halsted maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $484 to $692.
RBC Capital analyst Ryan Halsted maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $484 to $692.